Markus Hoffmann

Dr. Markus Hoffmann


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Viruses
Verified
Journal Article
Open access
PDF file
ASAnzhalika Sidarovich
Anzhalika Sidarovich
NKNadine Krüger
Nadine Krüger
CRCheila Rocha
Cheila Rocha
LGLuise Graichen
Luise Graichen
AKAmy Kempf
Amy Kempf
MHMarkus Hoffmann
Markus Hoffmann
The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) facilitates viral entry into host cells and is the key target for neutralizing antibodies. The SARS-CoV-2 lineage B.1.620 carries fifteen mutations in the S protein and is spread in Africa, the US and Europe, while lineage R.1 harbors four mutations in S and infections were observed in several countries, particularly Japan and the US. However, the impact of the mutations in B.1.620 and R.1 S proteins on antibody-mediated neutralization and host cell entry are largely unknown. Here, we report that these mutations are compatible with robust ACE2 binding and entry into cell lines, and they markedly reduce neutralization by vaccine-induced antibodies. Our results reveal evasion of neutralizing antibodies by B.1.620 and R.1, which might have contributed to the spread of these lineages.